Series B startup

Who invested in ViewPoint Therapeutics

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$35Mraised across 1 round since 2018, from 1 source

Latest round
Series B, $35MMar 2018
Investors
1
See who backed them

The rounds

  1. Mar 2018
    Series B$35M

    Source recordedSEC filing: $21M sold, first sale Mar 2018

Everyone who backed them

Mission BioCapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about ViewPoint Therapeutics

Who invested in ViewPoint Therapeutics?

ViewPoint Therapeutics's investors include Mission BioCapital.

How much has ViewPoint Therapeutics raised?

ViewPoint Therapeutics has raised $35M across 1 round since 2018.

When did ViewPoint Therapeutics last raise?

ViewPoint Therapeutics's most recent round was a Series B of $35M in Mar 2018.

What was ViewPoint Therapeutics's biggest round?

Its most recent round, $35M in Mar 2018, is also its largest on record.

Who backed ViewPoint Therapeutics first?

ViewPoint Therapeutics's first round on record, in Mar 2018, was backed by Mission BioCapital.

What stage is ViewPoint Therapeutics at?

ViewPoint Therapeutics's latest named round is a Series B, in Mar 2018.

Companies like ViewPoint Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.